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4 280 or pain on urination (dysuria), low back and pubic pain (Sobotová, 2011) . e development of urinary tract infection and its course depends on general defensive mechanisms of organism, the property of pathogenic factors, diagnosis and applied treatment (Wyszyńska, 1994; Sobotová, 2011) .
Virulence factors of uropathogenic Escherichia coli
Uropathogenic strains of E. coli (UPEC) harbour different virulence factors which enable them colonization and persistence in the urinary tract. e virulence factors are encoded by genes located at the selected regions of chromosomal DNA, plasmids and transpozons. e DNA fragments forming a complex of virulence determinants (adhesins, toxins, secretion mechanisms, capsules and iron uptake systems) are called pathogenicity islands (PAIs). PAIs are exible genetic elements, holding the mobility sequences, which are transferred horizontally between the bacterial cells (the mechanism of gene transfer important in the evolution of UPEC virulence) (Blum et al., 1994; Picard et al., 1999; Hacker and Kaper, 2000; Johnson and Kuskowski, 2000; Oelschlaeger et al., 2002; Johnson, 2003) .
Virulence determinants associated with UPEC include the family of adhesive fimbrial organelles, fimbrial polyadhesins and adhesive pili (P and type 1 pili, Dr family of adhesins, S and F1C fimbriae), polysacharide coatings (group II capsules), toxins (hemolysin, secreted autotransporter toxin, Sat and cytotoxic necrotizing factor), and siderophores (aerobactin system) (Oelschlaeger et al., 2002; Emödy et al., 2003; Arisoy et al., 2006; Yamamoto, 2007) .
Pili and fimbriae are necessary for attachment to specific uroepithelial cells which can activate mechanisms facilitating bacterial multiplications, invasion and sometimes growth as a biofilm. e presence of pili (especially type 1 pili) can also promote the development of local in ammation (Mulvey et al., 1998) . Among binding targets, host cell receptors, of adhesive fimbrial structures are manno-oligosaccharides (Connell et al., 1996; ankavel et al., 1997; BahraniMougeot et al., 2002) , digalactoside component of glycosphingolipids (Roberts et al., 1994) , glycoproteins and proteins (CD55/decay accelerating factor, DAF and carcinoembryonic antigen-related molecules, CEACAMs) (Nowicki et al., 1988; Berger et al., 2004; Servin 2005; LeBougenec and Servin, 2006; Korotkova et al., 2008a; 2008b; Guignot et al., 2009) .
Among the most frequent urovirulence factors with filamentous morphology are type 1 pili, P pili and Dr family of adhesins. Type 1 pili causes cystitis associated with the ability of bacteria to recognize the monomannosyl residues, localized on the bladder epithelium (Sokurenko et al., 1997) . However, P pili by recognition of P antigen in the renal tubular epithelium leads to acute pyelonephritis (Källenius et al., 1981) . In pregnant patients with pyelonephritis, P-and Dr-positve E. coli strains (representing gestational age-dependent profiles) predominate during the second and third trimester, respectively (Nowicki et al., 1994) .
e Dr adhesins are the third most common group of colonization factors of UPEC, behind type 1 and P pili (Nowicki et al., 2001) . ey are responsible for 25-50% cases of cystitis and 30% of pyelonephritis in pregnant woman (Labigne-Roussel and Falkow, 1988) . Dr adhesins can also increase the risk of recurrent UTIs (Foxman et al., 1995) .
e growing Dr superfamily of adhesins includes Dr hemagglutinin (Dr/DraE adhesin), Dr-II, F1845, Afa-I, -II, -III, -IV, -V, -VII and -VIII, Nfa-I, Aaf-I and Aaf-II (of human or animal origin). All the adhesins are encoded by gene clusters of similar organization. In most cases, they bind to the common epithelial cell receptor, DAF (Nowicki et al., 2001; Servin 2005; Le Bougenec and Servin, 2006) . Interaction of the Dr adhesin with DAF glycoprotein leads to the internalization of bacterial cells to the epithelial cells. Dr + E. coli strains are able to survive long-term in human epithelial cells (Goluszko et al., 1997; 1999) . In the kidneys of experimental animals the above E. coli strains can also persist for several months .
Dr hemagglutinin among the whole family of Dr adhesin is the only member which can bind to type IV collagen (Westerlund et al., 1989; Carnoy and Moseley, 1997) . DrI113T mutant totally lost its ability to bind type IV collagen (Carnoy and Moseley, 1997; . Besides type IV collagen and DAF, the DraE adhesin can interact with members of the carcinoembryonic antigen family, CEA-related cellular adhesion molecules, CEACAM1, CEACAM5 and CEACAM6 (Berger et al., 2004; Korotkova et al., 2008a; 2008b; Guignot et al., 2009) . Dr haemagglutinin also triggers the bacterial mobilization of α 5 β 1 integrin (Guignot et al., 2009 ).
e capsule material on the bacterial surface provides protection against complement mediated bactericidal e ect in the host organism and phagocytic engulfment. LPS molecules induce the cytokine synthesis (IL-1, TNFα) and stimulate the in ammantory response (Morrison and Ryan, 1987; Rietschel, et al., 1996) . Other surface located molecules can form a part of a secretory machinery of virulence factors exported outside the bacterial cells like the outer membrane haemin receptor protein termed ChuA (required to gain access to the source of iron ions) (Torres and Payne, 1997) .
Exported virulence factor, α-hemolysin, is responsible for a destruction of cytoplasmic membrane of erythrocytes, endothelial and renal epithelial cells which causes uncontrolled out ow of ions from the cells (Smith, 1963; Keane et al., 1987) . e serine autotransporter protease, Sat, also belonging to exported determinants, reveals a toxic activity against bladder or kidney cell lines (Guyer et al., 2002) . e toxin has an ability to induce vacuolization within the cytoplasm of human cells of urinary tract origin contributing to the pathogenicity of UPEC by damage of host tissues and increase of bacterial propagation. Another secreted factor, the cytotoxic necrotising factor 1, CNF1 evokes apoptosis of bladder epithelial cells (Caprioli et al., 1987; Fiorentini et al., 1997) . Siderophores, like aerobactin, found in 30-60% of uropathogenic E. coli strains are low molecular weight compounds exported from the bacterial cell to gain Fe 3+ cations from the host components chelating the iron. e process of iron utilization is controlled by farric-siderophore receptors located in the bacterial outer membrane (Guerinot, 1994; Braun et al., 1998; Schubert et al., 2002) .
Chaperone-usher pathway as the secretion mechanism of adhesive organelles of UPEC
A multitude of Gram-negative pathogens utilize the highly conserved secretion pathway termed chaperoneusher for the bioassembly of at least 30 diverse adhesive organelles that are required in host-pathogen interactions critical for the initial step of infection (Hung et al., 1996; anassi et al., 1998; Sauer et al., 2004) . Among those fibers, P and type 1 pili, expressed by uropathogenic E. coli strains, are mainly used as the model systems to understand their structure and function. e chaperone-usher secretion system is also studied on a basis of E. coli Dr family of adhesins and polymeric F1 capsular antigen of Yersinia pestis (Zavialov et al., 2003; Anderson et al., 2004; Pettigrew et al., 2004; Sauer et al., 2004; Piątek et al., 2005a; 2005b) . e chaperone-usher secretion system is based on two components, chaperone located in periplasmic space and usher inserted in the outer-membrane. Including the sequence analysis two immunoglobulin-like periplasmic chaperone families have been identified, FGL (F1-G1 long) named Caf1M-like with a long and exible loop (21-29 residues) between F1 and G1 β-strands and FGS (F1-G1 short) named PapD-like with a short loop (10-20 residues) connecting F1 and G1 β-strands (Zav'yalov et al., 1995; Hung et al., 1996; Saulino et al. 2000; Sauer et al., 2000; Zavialov et al., 2007) .
e division of chaperones is strictly connected with morphological properties of adhesive structures.
e FGL chaperone-assembled organelles, called fimbrial polyadhesins (diameter of 2 nm), consist of linear polymers of one or two types of protein subunits (each subunit possesses adhesive properties). e adhesive organelles have nonpilus, amorphous or capsule likemorphology. e FGS assembled organelles, termed adhesive pili (pilus rod of 10 nm diameter), are composite structures built from multiple di erent pilus subunits with single adhesive subunit at the tip (Hung et al., 1996; Nishiyama et al., 2005; Remaut et al., 2006; Zavialov et al., 2003; 2005; 2007) . e outer membrane molecular ushers form a conserved family of proteins (Fimbrial Usher Proteins, FUP) without any specific di erences in sequences involved in the assembly of fimbrial polyadhesins or adhesive pili ( anassi et al., 2002; Capitani et al., 2006a; 2006b; Zavialov et al., 2007) . e chaperones of both families play many functions in biogenesis of pili/fimbriae. ey stabilize subunits in the periplasm (a er secretion via the Sec pathway) by formation of soluble chaperone-subunit complexes, cap their interactive surfaces which prevents premature interactions of the subunits, aggregation and degradation by periplasmic proteases. ey also facilitate the folding of subunits a er their emergence from the inner membrane in semi-unfolded conformations and transport the subunits to an outer membrane molecular usher. All functions are determined by a donor strand complementation mechanism in which G1 β-strand of the chaperone and the portion of the F1-G1 loop complete the immunoglobulin fold of the subunit (Zav'yalov et al., 1995; Hung et al., 1996; anassi et al., 1998; Knight et al., 2000; Sauer et al., 1999; Zavialov et al., 2001; 2005; 2007; Remaut et al., 2006) . e ushers release the subunit from the complex with the chaperone in the periplasm, form an assembly polymerization platform of subunits in linear fibers/ pilus structures and secrete adhesive organelles via the oligomeric usher pores to the bacterial cell (Nishiyama et al., 2005; Remaut et al., 2006) . e pilus/fiber assembly is carried out by a donor strand exchange mechanism in which the amino terminal strand of a neighboring subunit replaces the G1 β-strand of the chaperone.
us, in the mature adhesive organelle every subunit is required for the complementation of the immunoglobulin fold of its neighbor (Barnhart et al., 2000) .
Present and future treatment of UTIs
Modern therapy of the urinary tract infections is based on their treatment with antibiotics. e choice of anti-bacterial treatment and the time of application is dependent on a clinical character of urinary tract infection and patient condition. One should take into consideration the course of drug action, the concentration of the medicine in urine, excretion in unaltered form, undesirable symptoms a er its application and the cost of treatment. e drugs with a long-term e ect and capacity of sequential treatment (initial parenteral administration of a drug and a continuation of treatment by the oral form of preparation) are recommended (Gutierrez, 1996) .
Increasing resistance of bacteria to antibiotics and understanding of pathogenesis of UTIs create the need for designing chemotherapeutics that target new molecular targets (Stamm and Hooton, 1993; Hooton and Levy, 2001; White and McDrmott, 2001; Gupta, 2003) . ere are several potential strategies which can be used in future to treat UTIs. One strategy blocking the colonization of urinary tract by uropathogens includes inhibition of pili/fimbriae biogenesis. Another strategy concerns the process of blocking of intracellular bacterial communities (IBC) which are cellular structures similar to biofilm preventing the bacteria from immune response and antibiotic therapy. e next strategy is connected with abolishing of binding of bacterial adhesins to host cellular receptors. e most promising approaches are related to inhibition of pili/ fimbriae biogenesis and blocking of bacterial adhesion (Wright and Hultgren, 2006) . e adhesion of bacterial cells can be blocked by using small molecules, so called adhesin inhibitors which strictly interact with the target adhesins (Firon et al., 1987; Ohlsson et al., 2002; Ofek et al., 2003) . Aromatic alpha-glycosides of mannose for a long time are considered to be excellent inhibitors of adhesion of type 1 piliated E. coli (mediated by FimH adhesin) to target tissues (Firon et al., 1987) . Fruit juices, especially cranberry juice, are widely used in the treatment of UTIs. Positive e ects of cranberry juice have also been observed in clinical trials (Avorn et al., 1994; Kontiokari et al., 2001; Di Martino et al., 2006) . e active inhibition ingredient in cranberry juice is fructose (Zafriri et al., 1989) . Fructose, as well as aryl mannosides, binds to FimH adhesin of type 1 pili ~ 15 times weaker than mannose (Bouckaert et al., 2005) (mannose-containing receptors of the bladder epithelium are critical for establishment of cystitis) (Connell et al., 1996; ankavel et al., 1997; Bahrani-Mougeot et al., 2002) , and tightly than the natural globoside, (Galα1-4Gal) (globoside-containing receptors present on the kidney epithelium are necessary for pyelonephritis) (Lund et al., 1987; Roberts et al., 1994) to PapG-II adhesin of type P pili. Among several variants of PapG adhesins, PapG-II and PapG-III are predominant for colonization of the upper urinary tract (Ström-berg et al., 1990; 1991; Striker et al., 1995) . Galabiose deri vatives apperar to be potent inhibitors of adhesion mediated by PapG adhesin of pap + E. coli strains (Ohlsson et al., 2002) . e surface adhesive organelles (pili/fimbriae) of uropathogenic E. coli strains as virulence factors target for the development of a new class of anti-infective agents called pilicides. e pilicides function by interfering with the chaperone and usher activity, thus preventing the biogenesis of pili/fimbriae (Pinkner et al., 2001; Svensson et al., 2001 ). E ective activity of pilicides has been demonstrated for type 1 and type P pili. In this case, the reduction of biogenesis of the studied adhesive structures, was observed (Hendenström et al., 2005; Pinkner et al., 2006; Chorell et al., 2010) . In both cases, inhibitors of adhesion and pilicides, further in vivo studies are required.
Among the traditional methods used in combating infectious diseases is vaccination. ere are high expectations about the vaccine based on the FimCH binary complex composed of chaperone and adhesin (encoded by type 1 piliated E. coli), which was tested in mice and cynomolgus monkeys. Vaccination of the studied animals with FimCH resulted in greater than 99% reduction of mucosal colonization (Langermann and Ballou WR Jr, 2001) and 75% reduction in both colonization and in ammation, respectively (Langerman et al., 2000) . Until now, there are no clinical trials performed on the basis of PapDG chaperone-adhesin complex (of P-piliated E. coli).
Finally, the best treatment should apply to the combination of bacterial adhesins and be directed to di erent sites of colonization by bacterial strains. e development of vaccines and anti-adhesive drugs can prevent anticipated and recurrent UTIs.
Summary
Urinary tract infections are very common health problem world wide. Most of these infections are caused by the uropathogenic E. coli strains (about 80%). Virulence of the bacterial strains is mainly determined by the surface-exposed adhesive polymeric structures (fimbriae/pili) responsible for recognition of the selected cellular receptors on the target cells. Interaction of the adhesive subunits with the specific receptors on the surface of host cells is the crucial step in the pathogenesis. Strong immunogenic properties of the adhesive polymeric structures are o en used to design vaccines based on the conserved antigenic domains of the adhesins (so called adhesin-based vaccines) which can be useful for the prevention of a number of di erent diseases. An alternative to adhesin-based vaccines is an inhibition of adhesion by using adhesin inhibitors interacting with target adhesin in many cases more tightly than the physiological ligands. Because of the crucial role of the adhesive organelles in the colonization of the invaded environment, their biogenesis is highly conserved among the multitude of Gram-negative bacteria. Detailed characteristics of the chaperones, a component of the chaperone-usher pathway, showed their usefulness as an ideal target for the developing of the potential drugs, termed pilicides. Such drugs, by interactions with chaperone and usher proteins, have the potential to block pili formation in a broad range of pathogenic bacteria parallel with the inhibition of adhesion and invasion of bacterial cells into the eucariotic cells.
